Haemoadapt

10+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

HaemoAdapt is a decision support application regarding the choice of the most appropriate therapy in hemophilia A and B for each individual patient developed by a prestigious medical team specialized in hematology, based on the 2022 BloodReviews publication ( BloodReviews 52 (2022) 100890) with the scientific endorsement of the Royal Victoria Eugenia Foundation and the collaboration of Novo Nordisk Spain.
Updated on
Nov 15, 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info
Data isn’t encrypted
You can request that data be deleted

What’s new

App para toma de decisiones terapéuticas en hemofilia A y B

App support

Phone number
+34919075901
About the developer
HEART AND BRAIN HEALTHCARE MARKETING SL.
admin@hnb.es
SATURNINO CALLEJA, 16 - 2 PLT 28002 MADRID Spain
+34 689 03 32 06

Similar apps